Incordex Corp. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q1 2025.

Location
Nuneaton, United Kingdom
Fiscal year end
30 June
Latest financial report
30 Jan 2026

Latest SEC snapshot (2025-03-31) highlights Return On Equity -349.7%, Return On Assets -54.4%, and Current Ratio 0.0x.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

0.0/100

Weak Confidence medium

Return On Equity

-350%

Metric score 0.0/100

Return On Assets

-54%

Metric score 0.0/100

Financial Health

Current Ratio
0x

Strengths

No strong signals yet.

Watchpoints

Return On Equity, Return On Assets, and Current Ratio

Key metrics snapshot

Return On Equity

-350%

YoY: -1729%

Industry median: 16% (n=29)

View history

Return On Assets

-54%

YoY: -1018%

Industry median: -35% (n=27)

View history

Current Ratio

0x

YoY: -100%

Industry median: 0.91x (n=26)

View history

Revenues YoY

-79%

YoY:

Industry median: 3.4% (n=16)

View history

NetIncomeLoss YoY

-756%

YoY:

Industry median: -4.6% (n=27)

View history

Profitability

Metric Latest value YoY change
Return On Equity -350% -1729%
Return On Assets -54% -1018%

Financial Health

Metric Latest value YoY change
Current Ratio 0x -100%
Debt-to-equity -3.96x -163%

Growth

Metric Latest value YoY change
Revenues YoY -79%
NetIncomeLoss YoY -756%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 6,450,000 0%
Common Stock, Shares, Outstanding 6,450,000 0%
Common Stock, Value, Issued $6,450 0%
Weighted Average Number of Shares Outstanding, Diluted 6,450,000 0%

Additional Metrics

Metric Latest value YoY change
General and Administrative Expense $32,668 -5.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2,612 -224%
Income Tax Expense (Benefit) $0
Earnings Per Share, Diluted 0
Assets, Current $0 -100%
Assets $0 -100%
Accounts Payable, Current $1,874 -87%
Liabilities, Current $1,874 -87%
Liabilities $1,874 -93%
Retained Earnings (Accumulated Deficit) $35,874 -32%
Stockholders' Equity Attributable to Parent $1,874 -127%
Liabilities and Equity $0 -100%
Common Stock, Shares Authorized 75,000,000 0%
Common Stock, Shares, Issued 6,450,000 0%
Common Stock, Par or Stated Value Per Share 0.001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $0 -100%
Additional Paid in Capital $27,550 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%